Sign in to download the Issue in PDF format.
Over the past decades, rheumatology has shaped as a rapidly developing scientific discipline with a wide range of interests and evolving priorities. Initial reports on the use of the first generation of biological agents for rheumatoid arthritis and other inflammatory rheumatic diseases in the early 2000s opened up new avenues for research at the interface of immunology, medical chemistry, and rheumatology. By improving the outcomes of suppressing autoimmunity and inflammation, rheumatologists across the world have increased the lifespan of their patients and encountered a number of new challenges. One such challenge is comorbidity, which necessitates multidisciplinary approach to rheumatic diseases, implementation of knowledge and skills from allied fields of science (i.e., cardiology, oncology, hematology). Authors of research studies covering the issue of comorbidity in rheumatic diseases are now targeting not only periodicals in rheumatology but also in allied fields of science with editorial and reviewer boards competent to process multidisciplinary research reports.
